Empagliflozin role in the treatment of type 2 diabetes with cardiovascular disease and subclinical cardiovascular disease in outpatient setting: case reports

: Journal of Diabetes, Metabolic Disorders & Control
: Rajesh Jain,¹ Mohammadreza Shoghli,² Muhammad Iqbal,³ AmitChauhan,⁴ Rachna Jain⁵

Keywords

type 2 diabetes, cardiovascular disease, subclinical cardiovascular disease, coronary artery disease, left ventricular mass index, peripheral arterial disease

© 2014-2025 MedCrave Group, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at www.medcrave.com
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera | Terms and Conditions | Privacy Policy

Testimonials

Empagliflozin role in the treatment of type 2 diabetes with cardiovascular disease and subclinical cardiovascular disease in outpatient setting: case reports

Keywords

Quick Links

Related Journals